Syntaxin-6, a Reliable Biomarker for Predicting the Prognosis of Patients with Cancer and the Effectiveness of Immunotherapy

Wenchao Li(Sun Yat-sen University), Changhua Zhang(Sun Yat-sen University), Xiancong Chen(The Seventh Affiliated Hospital of Sun Yat-sen University), Mingyu Huo(Sun Yat-sen University), Yulong He(The First Affiliated Hospital, Sun Yat-sen University), Yangjing Liao(Sun Yat-sen University), Songyao Chen(Sun Yat-sen University), Kuan Li(Southern University of Science and Technology), Yuan Zou(Southern Medical University), Hongfa Wei(Sun Yat-sen University), Cuncan Deng(Sun Yat-sen University), Yu Sun(Sun Yat-sen University)
Cancers
December 21, 2022
10.3390/cancers15010027
Cited by 7

Related Papers

NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance
|Nature|2024|473
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
|Journal of Cancer Research and Clinical Oncology|2014|414
Novel immunological and nutritional-based prognostic index for gastric cancer
|World Journal of Gastroenterology|2015|101
Associations of Mental Health and Personal Preventive Measure Compliance With Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study
|Journal of Medical Internet Research|2020|86
Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study
|Clinical Cancer Research|2019|61